
Defense-in-depth by mucosally administered anti-HIV dimeric IgA2 and systemic IgG1 mAbs: Complete protection of rhesus monkeys from mucosal SHIV challenge
Keywords: میمون رزوس; Ab; antibody; mAb; monoclonal antibody; nmAb; neutralizing monoclonal antibody; ADCC; antibody-dependent cellular cytotoxic activity; AID50; 50% animal infectious doses; C1; first conserved region; CTL; cytotoxic T lymphocyte; dIgA; dimeric IgA; Env; enve